ISPE

NOVEMBER 2, 2022

iSpeak Blog. Applying what has been learned over the last three years to update pharmaceutical companies’ approaches to development and implementation is key as the industry crafts its strategies in an increasingly digital and global environment. Strong and transparent communications and trust are tied to this.

Vaccines 98

Vaccines Pharmaceutical Companies Pharmaceutical Companies Hospitals 98

ISPE

MARCH 6, 2023

Trudy Patterson Mon, 03/06/2023 - 11:50 iSpeak Blog iSpeak Operations Data Challenges Limit the Value Realized from Pharma 4.0 Michael Krause 6 March 2023 Pharmaceutical and biotech portfolios continue to transition from high volume blockbusters to a diversified set of lower volume, targeted therapeutics.

Communication 97

Communication Pharmaceutical Companies Pharmaceutical Companies FDA 97

Pharma Marketing Network

AUGUST 9, 2023

Navigating these regulatory challenges is essential to ensure compliance, maintain trust, and effectively communicate the benefits and risks of pharmaceutical products. In this blog post, we will explore best practices for pharmaceutical companies to navigate the complex landscape of regulatory challenges in marketing.

Packaging 52

Packaging Labelling Communication Pharmaceutical Companies 52

Pharma Marketing Network

MAY 3, 2023

The pharmaceutical industry has undergone significant changes in recent years, with digital marketing playing an increasingly important role in the way companies communicate with customers and stakeholders.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Communication 52

Pharma Marketing Network

OCTOBER 14, 2024

These technologies enable pharmaceutical companies to analyze vast amounts of data quickly, identify potential drug candidates, and optimize clinical trials, ultimately accelerating the time-to-market for new therapies. Partnerships and collaborations are gaining traction as innovative marketing strategies in the pharma industry.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Communication 52

Pharma Marketing Network

OCTOBER 13, 2023

Multichannel marketing is an effective digital strategy for pharmaceutical companies to reach consumers and encourage them to purchase products. By utilizing multiple channels such as social media, email, and mobile applications, pharma companies can reach a wider audience and coordinate their efforts to create a unified message.

Pharmaceutical Companies 98

Pharmaceutical Companies Pharmaceutical Companies Communication 98

Pharma Marketing Network

OCTOBER 25, 2024

As patients become more digitally savvy, pharmaceutical companies can reach them where they are: on social media, search engines, and healthcare websites. Search Engine Optimization (SEO) for Pharma SEO is essential for ranking highly on search engines, and it can be a game-changer for pharmaceutical brands.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Communication 52

Omnicell

JANUARY 10, 2023

There was bipartisan support for the program at the hearing and support for measures such as requiring pharmaceutical companies to publish their prices in a password protected site on HRSA's website. Four of the five staffers originally involved in the investigation now work for or lobby for the pharmaceutical industry.

Hospitals 96

Hospitals Omnicell Insurance Documentation 96

Pharma Marketing Network

JULY 10, 2023

Pharmaceutical marketing is the process of communicating the benefits of a pharmaceutical product to potential patients and healthcare providers. It can be a complex and challenging process, as pharmaceutical companies must adhere to strict regulations while also developing creative and effective marketing campaigns.

Pharmaceutical Companies 40

Pharmaceutical Companies Pharmaceutical Companies Communication FDA 40

Pharma Marketing Network

AUGUST 9, 2023

Navigating these regulatory challenges is essential to ensure compliance, maintain trust, and effectively communicate the benefits and risks of pharmaceutical products. In this blog post, we will explore best practices for pharmaceutical companies to navigate the complex landscape of regulatory challenges in marketing.

Packaging 40

Packaging Labelling Communication Pharmaceutical Companies 40

Viseven

JULY 25, 2024

Promoting content worldwide When a pharmaceutical company publishes content, it often considers the norms and laws of the country in which it operates. But what if this company decides to expand worldwide? The truth is that MLR reviews are needed in 90% of cases, whether it is a website blog post or an important research paper.

Documentation 52

Documentation Communication Pharmaceutical Companies Pharmaceutical Companies 52

Viseven

NOVEMBER 9, 2022

Key Opinion Leaders play a critical role in the life sciences industry – pharmaceutical companies often engage them during clinical trials and drug commercialization. It’s a quantitative way to locate physicians leaders who influence the medical community. In other words, managed KOLs can be a real game-changer.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Communication Hospitals 52

Viseven

AUGUST 7, 2024

Medical writing refers to creating healthcare-related textual content that aims to improve doctor-patient communication and provide insights on industry topics. Medical writers must be outstanding communicators, capable of breaking down complex ideas for the public and healthcare professionals in a digestible way.

Communication 52

Communication Documentation Pharmaceutical Companies Pharmaceutical Companies 52

Viseven

SEPTEMBER 18, 2024

Just one blog post might be created by the whole team, involving subject-matter experts, marketers, regulatory specialists, and medical writers. Content fragmentation Most departments in many pharma companies still face siloes, which harms content production. Content should be created in accordance with all regulations and standards.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Communication 52

ISPE

NOVEMBER 28, 2022

ISPE Advancing Pharmaceutical Quality Program Complete. iSpeak Blog. ISPE Advancing Pharmaceutical Quality Program Complete. ISPE is pleased to announce the complete Advancing Pharmaceutical Quality Program (APQ) Program is now available with the release of the fifth and final guide. Internal Communication.

Documentation 52

Documentation Communication Pharmaceutical Companies Pharmaceutical Companies 52

Viseven

APRIL 11, 2023

This may include blog posts, whitepapers, videos, podcasts, or infographics. The most suitable formats for pharma are eDetailers, infographics, case studies , blog posts, articles, and so on. For example, blog articles and social media posts may be most effective during awareness.

Pharmaceutical Companies 40

Pharmaceutical Companies Pharmaceutical Companies Customer Service Dosage 40

PQA

MARCH 28, 2024

Our members include community and specialty pharmacy organizations, pharmacists and other healthcare providers, pharmacies, health plans, pharmacy benefit managers, life sciences, technology vendors, government agencies, health information technology partners, researchers, accrediting organizations and academia.

Specialty Pharmacies 40

Specialty Pharmacies Communication Pharmaceutical Companies Pharmaceutical Companies 40

PQA

MARCH 27, 2024

Our members include community and specialty pharmacy organizations, pharmacists and other healthcare providers, pharmacies, health plans, pharmacy benefit managers, life sciences, technology vendors, government agencies, health information technology partners, researchers, accrediting organizations and academia.

Specialty Pharmacies 40

Specialty Pharmacies Communication Pharmaceutical Companies Pharmaceutical Companies 40

Pharma Marketing Network

JUNE 11, 2020

RJ Lewis (EHS): So today everybody’s a publisher, part of the beauty of the web and even if you don’t have the technical skills for firing up a website or a blog, which is pretty easy. So whether you’re an advertiser or an event coordinator or a supplier in the industry, most of them have pretty active blogs.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Communication Labelling 52

The Infectious Pharmacist

APRIL 6, 2021

There must be some way to communicate information a little more positively, though. . To require a pharmaceutical company to perform a second randomized clinical trial in another 40,000 patients would be a waste of time and money, especially during a pandemic. Ok, so what did the press release say? variant, either.

Vaccines 52

Vaccines Pharmaceutical Companies Pharmaceutical Companies Communication 52

Pharma Marketing Network

JUNE 11, 2020

I landed on John Mack’s blog, as I’ve done many, many times in the past to look up something. What do you what are you doing with the blog? I didn’t ask them to make a blog about it or anything, go back to the FDA, you thought about wearing the Hawaiian shirt. And he said I’m not sure.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Communication FDA 52

The FDA Law Blog

AUGUST 22, 2023

The letter itself is pretty typical of what we would expect to see from OPDP – prioritizing a communication that includes no safety information despite numerous efficacy claims, calling out an efficacy claim as misleading, and failing to submit promotional material on Form 2253. So, what gives?

FDA 40

FDA Pharmaceutical Companies Pharmaceutical Companies Communication 40

The Physician Pharmacist

NOVEMBER 2, 2023

link] In this insightful blog post, we delve into the diverse facets of Dr. Harris's remarkable career: Holistic Healthcare Visionary : Dr. Harris is not your typical healthcare professional. ⚡️ For more resources to get started, check out some of our other blog post content! And just kind of figure it out on the way.

Medical Schools 52

Medical Schools Compounding Hospitals Compounding Pharmacies 52

Omnicell

SEPTEMBER 5, 2022

Pharma’s Challenges to 340B During July and August, several large pharmaceutical companies challenged the operation of the 340B program. For more information on the programs history and a digestable synopsis of the 340B program explained , visit our blog! John Thune (R-S.D.), Debbie Stabenow (D-Mich.),

Hospitals 52

Hospitals Pharmaceutical Companies Pharmaceutical Companies Omnicell 52